Pascal and Francis Bibliographic Databases


Search results

Your search


Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 995

  • Page / 40

Selection :

  • and

Preparation of embolic NEMs loading capecitabineYUANGANG LIU; PENG HE; SHIBIN WANG et al.Journal of materials science. Materials in medicine. 2013, Vol 24, Num 1, pp 155-160, issn 0957-4530, 6 p.Article

Disparition de kératoses actiniques avec la capécitabine = Resolution of actinic keratosis with capecetabinSCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 11, pp 759-760, issn 0151-9638, 2 p.Article

Case 1. Pseudomyxoma peritonei: Response to capecitabineLEVITZ, Jason S; SUGARBAKER, Paul H; LICHTMAN, Stuart M et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1518-1520, issn 0732-183X, 3 p.Article

Capecitabine- induced multifocal leukoencephalopathy : A report of five casesVIDENOVIC, A; SEMENOV, I; RAIZER, J. J et al.Neurology. 2005, Vol 65, Num 11, pp 1792-1794, issn 0028-3878, 3 p.Article

Genital Erythrodysesthesia as a Severe Manifestation of Capecitabine Therapy: A Report of 3 CasesFLETA-ASIN, Beatriz; ALCANTARA-GONZALEZ, Javier; ALONSO-CASTRO, Leticia et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1123-1124, issn 0003-987X, 2 p.Article

Resolving actinic keratoses: an expected side-effect of capecitabine therapyAL-NIAIMI, F; LYON, C.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 1, pp 68-69, issn 0307-6938, 2 p.Article

Capecitabine-Induced Chest Pain Relieved by DiltiazemAMBROSY, Andrew P; KUNZ, Pamela L; FISHER, George A et al.The American journal of cardiology. 2012, Vol 110, Num 11, pp 1623-1626, issn 0002-9149, 4 p.Article

Capecitabine-induced coronary vasospasm: A case reportRIZVI, Asad A; SCHAUER, Peter; OWLIA, Dariush et al.Angiology. 2004, Vol 55, Num 1, pp 93-97, issn 0003-3197, 5 p.Article

Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabineBOOTH, J. A; BOOTH, C; CRAWFORD, S. Michael et al.Clinical medicine. 2011, Vol 11, Num 5, issn 1470-2118, p. 511Article

Phase IB Study of the mTOR Inhibitor Ridaforolimus With CapecitabinePEROTTI, Antonella; LOCATELLI, Alberta; ALBANELL, Joan et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4554-4561, issn 0732-183X, 8 p.Article

Successful Treatment of HER-2-Positive Metastatic Apocrine Carcinoma of the Skin with Lapatinib and CapecitabineHIDAKA, Takanori; FUJIMURA, Taku; WATABE, Akiko et al.Acta dermato-venereologica. 2012, Vol 92, Num 6, pp 654-655, issn 0001-5555, 2 p.Article

Complete Response of Metastatic Malignant Hidradenocarcinoma to Capecitabine TreatmentLERNER, Adam; BECKFORD, Angela; UGENT, Steve et al.Archives of dermatology (1960). 2011, Vol 147, Num 8, pp 998-999, issn 0003-987X, 2 p.Article

Exudative, Nonhealing Scalp: A Complication of Systemic Chemotherapy With Capecitabine and BevacizumabBLACK, Jeanette M; HODARI, Kafele T; ROGERS, Nicole et al.Archives of dermatology (1960). 2011, Vol 147, Num 1, pp 134-135, issn 0003-987X, 2 p.Article

A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving CapecitabineHENIN, E; YOU, B; TOD, M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 4, pp 418-425, issn 0009-9236, 8 p.Article

Focal Acral Hyperpigmentation in a Patient Undergoing Chemotherapy with CapecitabineVILLALON, Guillermo; MARTIN, Jose M; PINAZO, Maria I et al.American journal of clinical dermatology. 2009, Vol 10, Num 4, pp 261-263, issn 1175-0561, 3 p.Article

Capecitabine-Induced Inflammation of Actinic Keratosis: Case Report and Literature ReviewSTANCIU, Monica; AUBUT, Nicolas; GAGNE, Eric et al.Journal of cutaneous medicine and surgery. 2012, Vol 16, Num 5, pp 298-299, issn 1203-4754, 2 p.Article

Toxicité sévère à la capécitabine liée à un déficit enzymatique en dihydropyrimidine déshydrogénase (DPD) = Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiencyCOURSIER, S; MARTELET, S; GUILLERMET, A et al.Gastroentérologie clinique et biologique. 2010, Vol 34, Num 3, pp 218-223, issn 0399-8320, 6 p.Article

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulationMILANO, G; FERRERO, J.-M; FRANCOIS, E et al.British journal of cancer. 2004, Vol 91, Num 4, pp 613-617, issn 0007-0920, 5 p.Article

Hyperpigmentation à la capecitabine suivie de syndrome mains-pieds: une nouvelle observation = Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: A new case reportAGHARBI, F.-Z; MEZIANE, M; BENHEMMNE, H et al.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 3, pp 221-222, issn 0151-9638, 2 p.Article

A phase II study of metronomic paclitaxel/cyclophosphamide/ capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancerMASUDA, N; HIGAKI, K; MORITA, S et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 229-238, issn 0344-5704, 10 p.Article

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancerMUHAMMAD WASIF SAIF; JIA LI; LAMB, Lynne et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 373-380, issn 0344-5704, 8 p.Article

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancerSTRICKLER, John H; MCCALL, Shannon; MEADOWS, Kellen L et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 330-339, issn 0167-6997, 10 p.Article

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation studyISAKOFF, S. J; WANG, D; CAMPONE, M et al.British journal of cancer. 2014, Vol 111, Num 11, pp 2058-2066, issn 0007-0920, 9 p.Article

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04O'CONNELL, Michael J; COLANGELO, Linda H; PARDA, David S et al.Journal of clinical oncology. 2014, Vol 32, Num 18, pp 1927-1934, issn 0732-183X, 8 p.Conference Paper

Docetaxel―cisplatin might be superior to docetaxel―capecitabine in the first-line treatment of metastatic triple-negative breast cancerFAN, Y; XU, B. H; YUAN, P et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1219-1225, issn 0923-7534, 7 p.Article

  • Page / 40